Concepts (246)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Neurons | 24 | 2018 | 131 | 5.060 |
Why?
|
| Brain Injuries, Traumatic | 6 | 2024 | 45 | 3.640 |
Why?
|
| Brain Injuries | 12 | 2022 | 31 | 2.900 |
Why?
|
| Cell Culture Techniques | 10 | 2012 | 26 | 2.000 |
Why?
|
| Animals | 38 | 2024 | 1817 | 1.720 |
Why?
|
| Rats | 23 | 2024 | 251 | 1.720 |
Why?
|
| Rats, Sprague-Dawley | 21 | 2024 | 131 | 1.670 |
Why?
|
| Disease Models, Animal | 9 | 2021 | 242 | 1.550 |
Why?
|
| Metabolomics | 2 | 2024 | 6 | 1.530 |
Why?
|
| Stress, Mechanical | 10 | 2018 | 31 | 1.470 |
Why?
|
| Cell Membrane | 5 | 2011 | 51 | 1.440 |
Why?
|
| Laminin | 7 | 2011 | 8 | 1.430 |
Why?
|
| Tissue Engineering | 6 | 2011 | 15 | 1.420 |
Why?
|
| Cell Membrane Permeability | 7 | 2018 | 13 | 1.330 |
Why?
|
| Fibronectins | 6 | 2009 | 13 | 1.180 |
Why?
|
| Cell Survival | 13 | 2015 | 57 | 1.150 |
Why?
|
| Cells, Cultured | 19 | 2015 | 134 | 1.070 |
Why?
|
| Spectrometry, Mass, Electrospray Ionization | 2 | 2024 | 7 | 1.030 |
Why?
|
| Cerebral Cortex | 9 | 2018 | 53 | 1.030 |
Why?
|
| Brain Concussion | 1 | 2024 | 8 | 0.890 |
Why?
|
| Astrocytes | 5 | 2015 | 16 | 0.880 |
Why?
|
| Common Data Elements | 2 | 2021 | 3 | 0.860 |
Why?
|
| Blast Injuries | 2 | 2022 | 2 | 0.860 |
Why?
|
| Physical Stimulation | 5 | 2007 | 17 | 0.840 |
Why?
|
| Cell Movement | 4 | 2011 | 64 | 0.840 |
Why?
|
| Brain | 8 | 2024 | 286 | 0.820 |
Why?
|
| Coculture Techniques | 6 | 2011 | 11 | 0.820 |
Why?
|
| Biomarkers | 2 | 2024 | 87 | 0.790 |
Why?
|
| Trauma, Nervous System | 2 | 2011 | 2 | 0.770 |
Why?
|
| Hydrogels | 3 | 2020 | 15 | 0.680 |
Why?
|
| Stem Cell Transplantation | 3 | 2009 | 6 | 0.660 |
Why?
|
| Cell Death | 7 | 2018 | 21 | 0.600 |
Why?
|
| Lipid Metabolism | 1 | 2018 | 14 | 0.590 |
Why?
|
| Models, Neurological | 4 | 2015 | 44 | 0.590 |
Why?
|
| Shear Strength | 6 | 2011 | 8 | 0.580 |
Why?
|
| Neural Stem Cells | 3 | 2011 | 4 | 0.540 |
Why?
|
| Coated Materials, Biocompatible | 3 | 2015 | 11 | 0.540 |
Why?
|
| Stem Cells | 3 | 2014 | 33 | 0.540 |
Why?
|
| Male | 11 | 2024 | 2765 | 0.540 |
Why?
|
| Methylcellulose | 3 | 2011 | 3 | 0.520 |
Why?
|
| Tissue Scaffolds | 3 | 2011 | 10 | 0.490 |
Why?
|
| Cell Differentiation | 3 | 2011 | 75 | 0.480 |
Why?
|
| Biomedical Engineering | 2 | 2011 | 6 | 0.470 |
Why?
|
| Microfluidic Analytical Techniques | 2 | 2011 | 5 | 0.430 |
Why?
|
| Neurites | 3 | 2010 | 7 | 0.430 |
Why?
|
| Biocompatible Materials | 3 | 2011 | 23 | 0.420 |
Why?
|
| Mice | 10 | 2014 | 719 | 0.400 |
Why?
|
| Biomechanical Phenomena | 3 | 2018 | 176 | 0.400 |
Why?
|
| Spinal Cord Injuries | 2 | 2009 | 23 | 0.390 |
Why?
|
| Animals, Newborn | 6 | 2011 | 37 | 0.390 |
Why?
|
| Biomedical Research | 1 | 2011 | 12 | 0.380 |
Why?
|
| Neurobiology | 1 | 2011 | 1 | 0.360 |
Why?
|
| Collagen | 2 | 2009 | 34 | 0.350 |
Why?
|
| Integrin beta1 | 2 | 2014 | 10 | 0.350 |
Why?
|
| Mechanotransduction, Cellular | 3 | 2008 | 5 | 0.330 |
Why?
|
| Perfusion | 2 | 2007 | 9 | 0.330 |
Why?
|
| Micro-Electrical-Mechanical Systems | 1 | 2009 | 1 | 0.320 |
Why?
|
| Epoxy Compounds | 1 | 2009 | 2 | 0.320 |
Why?
|
| Nerve Degeneration | 1 | 2009 | 8 | 0.320 |
Why?
|
| Polymers | 1 | 2009 | 42 | 0.310 |
Why?
|
| Female | 8 | 2024 | 2811 | 0.310 |
Why?
|
| Graft Survival | 1 | 2007 | 4 | 0.290 |
Why?
|
| Neuroprotective Agents | 1 | 2007 | 13 | 0.280 |
Why?
|
| Brain Chemistry | 1 | 2007 | 6 | 0.280 |
Why?
|
| Corpus Striatum | 2 | 2011 | 6 | 0.260 |
Why?
|
| Action Potentials | 1 | 2005 | 28 | 0.250 |
Why?
|
| Nerve Net | 1 | 2005 | 46 | 0.250 |
Why?
|
| Ion Mobility Spectrometry | 1 | 2024 | 1 | 0.230 |
Why?
|
| In Situ Nick-End Labeling | 3 | 2010 | 5 | 0.230 |
Why?
|
| Pregnancy | 4 | 2011 | 103 | 0.230 |
Why?
|
| Electrodes, Implanted | 2 | 2015 | 20 | 0.230 |
Why?
|
| Sphingolipids | 1 | 2024 | 1 | 0.220 |
Why?
|
| Organoids | 1 | 2022 | 1 | 0.210 |
Why?
|
| Cell Proliferation | 3 | 2009 | 120 | 0.200 |
Why?
|
| Learning | 1 | 2022 | 50 | 0.200 |
Why?
|
| Multipotent Stem Cells | 1 | 2002 | 1 | 0.200 |
Why?
|
| Mice, Inbred C57BL | 4 | 2011 | 195 | 0.190 |
Why?
|
| Hippocampus | 2 | 2018 | 73 | 0.190 |
Why?
|
| Humans | 7 | 2022 | 5476 | 0.190 |
Why?
|
| Gels | 2 | 2013 | 5 | 0.190 |
Why?
|
| Apoptosis | 3 | 2016 | 55 | 0.190 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2020 | 1 | 0.180 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2020 | 14 | 0.180 |
Why?
|
| Culture Media | 3 | 2011 | 18 | 0.180 |
Why?
|
| Equipment Failure Analysis | 4 | 2008 | 15 | 0.160 |
Why?
|
| Microfluidics | 2 | 2009 | 8 | 0.160 |
Why?
|
| Equipment Design | 4 | 2008 | 73 | 0.160 |
Why?
|
| Finite Element Analysis | 1 | 2018 | 8 | 0.150 |
Why?
|
| Ions | 1 | 2018 | 9 | 0.150 |
Why?
|
| Phosphatidylcholines | 1 | 2018 | 3 | 0.150 |
Why?
|
| Lipid Bilayers | 1 | 2018 | 14 | 0.150 |
Why?
|
| Maze Learning | 2 | 2009 | 27 | 0.150 |
Why?
|
| Software | 1 | 2018 | 59 | 0.150 |
Why?
|
| Chromatography, Liquid | 1 | 2018 | 38 | 0.150 |
Why?
|
| Molecular Dynamics Simulation | 1 | 2018 | 33 | 0.150 |
Why?
|
| Tandem Mass Spectrometry | 1 | 2018 | 68 | 0.140 |
Why?
|
| Immunohistochemistry | 3 | 2013 | 30 | 0.130 |
Why?
|
| Epistasis, Genetic | 1 | 2016 | 3 | 0.130 |
Why?
|
| Cell Cycle | 1 | 2016 | 11 | 0.130 |
Why?
|
| Time Factors | 3 | 2011 | 176 | 0.130 |
Why?
|
| Green Fluorescent Proteins | 2 | 2009 | 24 | 0.130 |
Why?
|
| Glial Fibrillary Acidic Protein | 3 | 2015 | 8 | 0.130 |
Why?
|
| Gene Regulatory Networks | 1 | 2016 | 35 | 0.130 |
Why?
|
| Databases, Factual | 1 | 2015 | 31 | 0.120 |
Why?
|
| Maleimides | 1 | 2015 | 1 | 0.120 |
Why?
|
| Peptide Hydrolases | 1 | 2015 | 1 | 0.120 |
Why?
|
| Interleukin 1 Receptor Antagonist Protein | 1 | 2015 | 2 | 0.120 |
Why?
|
| Polyethylene Glycols | 1 | 2015 | 28 | 0.120 |
Why?
|
| Osteocalcin | 1 | 2014 | 1 | 0.120 |
Why?
|
| Twist-Related Protein 1 | 1 | 2014 | 1 | 0.120 |
Why?
|
| Integrases | 1 | 2014 | 4 | 0.120 |
Why?
|
| Computer Simulation | 2 | 2006 | 188 | 0.120 |
Why?
|
| Gene Silencing | 1 | 2014 | 6 | 0.120 |
Why?
|
| Repressor Proteins | 1 | 2014 | 14 | 0.120 |
Why?
|
| Cell Adhesion | 3 | 2015 | 10 | 0.120 |
Why?
|
| Bone and Bones | 1 | 2014 | 17 | 0.120 |
Why?
|
| Phenotype | 2 | 2014 | 73 | 0.120 |
Why?
|
| Transcription Factors | 1 | 2014 | 69 | 0.110 |
Why?
|
| Surface Properties | 2 | 2015 | 77 | 0.110 |
Why?
|
| Materials Testing | 2 | 2011 | 19 | 0.100 |
Why?
|
| Embryo, Mammalian | 2 | 2014 | 30 | 0.100 |
Why?
|
| Cytochromes c | 1 | 2012 | 2 | 0.100 |
Why?
|
| Microdialysis | 1 | 2012 | 4 | 0.100 |
Why?
|
| Microglia | 2 | 2015 | 11 | 0.100 |
Why?
|
| Nerve Regeneration | 1 | 2011 | 1 | 0.100 |
Why?
|
| Peripheral Nerve Injuries | 1 | 2011 | 1 | 0.100 |
Why?
|
| Mass Screening | 1 | 2011 | 11 | 0.100 |
Why?
|
| Nervous System Diseases | 1 | 2011 | 5 | 0.100 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2011 | 19 | 0.100 |
Why?
|
| Cryopreservation | 1 | 2011 | 3 | 0.090 |
Why?
|
| Freezing | 1 | 2011 | 4 | 0.090 |
Why?
|
| Embryonic Stem Cells | 1 | 2011 | 10 | 0.090 |
Why?
|
| Cognition Disorders | 1 | 2011 | 46 | 0.090 |
Why?
|
| Dimethylpolysiloxanes | 1 | 2011 | 5 | 0.090 |
Why?
|
| Microtechnology | 1 | 2011 | 7 | 0.090 |
Why?
|
| Nervous System | 1 | 2011 | 5 | 0.090 |
Why?
|
| Mechanical Phenomena | 1 | 2011 | 10 | 0.090 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2010 | 16 | 0.090 |
Why?
|
| Fluoresceins | 2 | 2008 | 4 | 0.090 |
Why?
|
| Motor Activity | 2 | 2011 | 66 | 0.090 |
Why?
|
| Gold | 1 | 2011 | 49 | 0.090 |
Why?
|
| Neuropsychological Tests | 1 | 2011 | 176 | 0.090 |
Why?
|
| Alzheimer Disease | 1 | 2011 | 90 | 0.090 |
Why?
|
| Mice, Knockout | 2 | 2007 | 143 | 0.080 |
Why?
|
| Dextrans | 1 | 2009 | 4 | 0.080 |
Why?
|
| Fluorescein-5-isothiocyanate | 1 | 2009 | 4 | 0.080 |
Why?
|
| Isoquinolines | 1 | 2009 | 5 | 0.080 |
Why?
|
| Axons | 1 | 2009 | 18 | 0.080 |
Why?
|
| Flow Injection Analysis | 1 | 2008 | 1 | 0.080 |
Why?
|
| Serum Albumin, Bovine | 1 | 2008 | 20 | 0.070 |
Why?
|
| Organ Culture Techniques | 1 | 2007 | 4 | 0.070 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2007 | 3 | 0.070 |
Why?
|
| Prostatic Neoplasms | 1 | 2008 | 21 | 0.070 |
Why?
|
| Phagocytes | 1 | 2007 | 1 | 0.070 |
Why?
|
| Foreign-Body Reaction | 1 | 2007 | 1 | 0.070 |
Why?
|
| Polyethylene Terephthalates | 1 | 2007 | 1 | 0.070 |
Why?
|
| Swimming | 1 | 2007 | 5 | 0.070 |
Why?
|
| Cell Enlargement | 1 | 2007 | 1 | 0.070 |
Why?
|
| Cell Count | 1 | 2007 | 33 | 0.070 |
Why?
|
| Tissue Culture Techniques | 1 | 2007 | 2 | 0.070 |
Why?
|
| Macrophage Activation | 1 | 2007 | 2 | 0.070 |
Why?
|
| Cytokines | 1 | 2007 | 37 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 1 | 2007 | 24 | 0.070 |
Why?
|
| Extracellular Matrix Proteins | 1 | 2007 | 12 | 0.070 |
Why?
|
| Cell Line | 1 | 2006 | 86 | 0.060 |
Why?
|
| Elasticity | 1 | 2005 | 35 | 0.060 |
Why?
|
| Integrin alpha5beta1 | 1 | 2004 | 1 | 0.060 |
Why?
|
| Integrin alpha6beta1 | 1 | 2004 | 1 | 0.060 |
Why?
|
| Spheroids, Cellular | 1 | 2004 | 11 | 0.060 |
Why?
|
| Antibodies | 1 | 2004 | 28 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 2004 | 14 | 0.060 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2002 | 1 | 0.050 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2002 | 9 | 0.050 |
Why?
|
| Luminescent Proteins | 1 | 2002 | 7 | 0.050 |
Why?
|
| Mice, Transgenic | 1 | 2002 | 50 | 0.050 |
Why?
|
| Gene Deletion | 2 | 2014 | 15 | 0.050 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2020 | 37 | 0.040 |
Why?
|
| Phospholipids | 1 | 2018 | 4 | 0.040 |
Why?
|
| Models, Theoretical | 1 | 2018 | 78 | 0.040 |
Why?
|
| Cyclin D1 | 1 | 2016 | 1 | 0.030 |
Why?
|
| bcl-2-Associated X Protein | 1 | 2016 | 1 | 0.030 |
Why?
|
| Cyclin D2 | 1 | 2016 | 1 | 0.030 |
Why?
|
| Microarray Analysis | 1 | 2016 | 8 | 0.030 |
Why?
|
| STAT3 Transcription Factor | 1 | 2016 | 5 | 0.030 |
Why?
|
| Brain Hemorrhage, Traumatic | 1 | 2015 | 1 | 0.030 |
Why?
|
| Meta-Analysis as Topic | 1 | 2015 | 4 | 0.030 |
Why?
|
| Laboratories | 1 | 2015 | 5 | 0.030 |
Why?
|
| Reference Standards | 1 | 2015 | 13 | 0.030 |
Why?
|
| Algorithms | 1 | 2018 | 276 | 0.030 |
Why?
|
| Models, Animal | 1 | 2015 | 25 | 0.030 |
Why?
|
| Public Health | 1 | 2015 | 22 | 0.030 |
Why?
|
| Computational Biology | 1 | 2015 | 42 | 0.030 |
Why?
|
| Chondroitin Sulfates | 1 | 2015 | 1 | 0.030 |
Why?
|
| Hydrogel, Polyethylene Glycol Dimethacrylate | 1 | 2015 | 1 | 0.030 |
Why?
|
| Blood-Brain Barrier | 1 | 2015 | 7 | 0.030 |
Why?
|
| Molecular Sequence Data | 1 | 2015 | 50 | 0.030 |
Why?
|
| Inflammation Mediators | 1 | 2015 | 10 | 0.030 |
Why?
|
| Lipopolysaccharides | 1 | 2015 | 15 | 0.030 |
Why?
|
| Amino Acid Sequence | 1 | 2015 | 54 | 0.030 |
Why?
|
| Sp7 Transcription Factor | 1 | 2014 | 1 | 0.030 |
Why?
|
| Bone Development | 1 | 2014 | 1 | 0.030 |
Why?
|
| Incisor | 1 | 2014 | 1 | 0.030 |
Why?
|
| Skull | 1 | 2014 | 1 | 0.030 |
Why?
|
| Embryo Loss | 1 | 2014 | 1 | 0.030 |
Why?
|
| Immunoglobulin G | 1 | 2015 | 26 | 0.030 |
Why?
|
| Femur | 1 | 2014 | 4 | 0.030 |
Why?
|
| Bone Density | 1 | 2014 | 6 | 0.030 |
Why?
|
| Calcification, Physiologic | 1 | 2014 | 2 | 0.030 |
Why?
|
| X-Ray Microtomography | 1 | 2014 | 5 | 0.030 |
Why?
|
| Gene Expression Regulation | 1 | 2015 | 77 | 0.030 |
Why?
|
| Antigens, Differentiation, Myelomonocytic | 1 | 2013 | 1 | 0.030 |
Why?
|
| Antigens, CD | 1 | 2013 | 6 | 0.030 |
Why?
|
| CD11b Antigen | 1 | 2013 | 2 | 0.030 |
Why?
|
| Neuroglia | 1 | 2013 | 9 | 0.030 |
Why?
|
| Molecular Weight | 1 | 2012 | 7 | 0.020 |
Why?
|
| Early Diagnosis | 1 | 2011 | 5 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2011 | 18 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2011 | 19 | 0.020 |
Why?
|
| Nanotechnology | 1 | 2012 | 29 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2011 | 32 | 0.020 |
Why?
|
| Verbal Learning | 1 | 2011 | 13 | 0.020 |
Why?
|
| Cryoprotective Agents | 1 | 2011 | 1 | 0.020 |
Why?
|
| Logistic Models | 1 | 2011 | 69 | 0.020 |
Why?
|
| Peripheral Nerves | 1 | 2011 | 1 | 0.020 |
Why?
|
| Electrophysiological Phenomena | 1 | 2011 | 10 | 0.020 |
Why?
|
| Electrodes | 1 | 2011 | 17 | 0.020 |
Why?
|
| Prospective Studies | 1 | 2011 | 132 | 0.020 |
Why?
|
| Memory | 1 | 2011 | 55 | 0.020 |
Why?
|
| Parietal Lobe | 1 | 2011 | 18 | 0.020 |
Why?
|
| Executive Function | 1 | 2011 | 75 | 0.020 |
Why?
|
| Functional Laterality | 1 | 2011 | 38 | 0.020 |
Why?
|
| Attention | 1 | 2011 | 77 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2011 | 284 | 0.020 |
Why?
|
| Bioreactors | 1 | 2009 | 6 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2011 | 212 | 0.020 |
Why?
|
| Temperature | 1 | 2009 | 62 | 0.020 |
Why?
|
| Cognition | 1 | 2011 | 174 | 0.020 |
Why?
|
| Aged | 1 | 2011 | 859 | 0.020 |
Why?
|
| Plasma | 1 | 2007 | 6 | 0.020 |
Why?
|
| Cell Line, Tumor | 1 | 2008 | 175 | 0.020 |
Why?
|
| Needles | 1 | 2007 | 1 | 0.020 |
Why?
|
| Dizocilpine Maleate | 1 | 2003 | 3 | 0.010 |
Why?
|
| Excitatory Amino Acid Antagonists | 1 | 2003 | 7 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 2003 | 19 | 0.010 |
Why?
|
| Calcium | 1 | 2003 | 30 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 2003 | 32 | 0.010 |
Why?
|